These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 1023835

  • 1. [Use of cyclophosphamide in membranoproliferative glomerulonephritis].
    Wills H, Villarreal H.
    Arch Inst Cardiol Mex; 1976; 46(6):770-5. PubMed ID: 1023835
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cyclophosphamide in the treatment of glomerulonephritis.
    Ibels LS, Palmer AA, Mahony JF, Stewart JH.
    Prog Biochem Pharmacol; 1974; 9():65-81. PubMed ID: 4438383
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
    Belovezhdov N.
    Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA.
    Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Acute pharmacological block of the renin-angiotensin system and the recovery of intrarenal hemodynamics in patients with chronic glomerulonephritis].
    Kutyrina IM, Tareeva IE, Zverev KV, Rogov VA.
    Ter Arkh; 1993; 65(6):13-7. PubMed ID: 8378838
    [Abstract] [Full Text] [Related]

  • 15. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H, Vaccaro Torres CE, Lessa I, Azevêdo Vinhaes L.
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract] [Full Text] [Related]

  • 16. Monoclonal IgG cryoglobulinemia with secondary development of glomerulonephritis and nephrotic syndrome.
    Bengtsson U, Larsson O, Lindstedt G, Svalander C.
    Q J Med; 1975 Jul; 44(175):491-503. PubMed ID: 1178819
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 19. Nephrotic syndrome in the elderly. A retrospective study in steroid-treated patients.
    Palmieri PF, Bonomini M, Di Mizio G, Manfrini V, Summa R, Stuard S, Albertazzi A.
    Contrib Nephrol; 1993 Oct; 105():58-64. PubMed ID: 8252872
    [No Abstract] [Full Text] [Related]

  • 20. [Cyclophosphamide therapy of nephrotic syndrome in childhood].
    Krepler P, Rosenkranz A, Obiditsch-Mayer I, Stockinger L, Schatz H, Fritzsche H.
    Arch Kinderheilkd; 1970 Oct; 181(3):268-82. PubMed ID: 4922851
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.